4//SEC Filing
Scherle Peggy 4
Accession 0001209191-21-048688
CIK 0001678660other
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 7:27 PM ET
Size
11.8 KB
Accession
0001209191-21-048688
Insider Transaction Report
Form 4
Scherle Peggy
Chief Scientific Officer
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-07-27−20,000→ 36,460 totalExercise: $1.43Exp: 2028-11-12→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2021-07-27$1.43/sh+20,000$28,600→ 192,920 total - Sale
Common Stock
2021-07-27$36.09/sh−680$24,540→ 172,920 total - Sale
Common Stock
2021-07-27$35.45/sh−19,320$684,840→ 173,600 total
Footnotes (5)
- [F1]Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met.
- [F2]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F5]The stock option vested as to 25% of the total shares monthly beginning on November 13, 2019, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
Documents
Issuer
Prelude Therapeutics Inc
CIK 0001678660
Entity typeother
Related Parties
1- filerCIK 0001824632
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 7:27 PM ET
- Size
- 11.8 KB